Banking on biologics

American Laboratory

January 2014

Biologics means big bucks and big rewards. The pharma industry is keen to capitalize on this success as revenues are tipped to reach over $407 billion by 2018. By this time, more than 50% of the top 100 selling drugs will be biologics. 

Read the full article here »